Clinical evaluation of Terumo membrane type plasma separator (GDS-1).

DOI

Bibliographic Information

Other Title
  • テルモ膜型血しょう分離装置（ＧＤＳ‐１）の臨床評価

Search this article

Description

To add to the traditional method of blood separation by centrifugation, a membrane method has in recent years been coming into wide clinical use in treating autoimmune diseases by plasma exchange. The membrane method which not only is easy but also needs simple equipment has been the focus of attention as a new means to collect blood components, especially plasma.<br>This paper discusses the results of clinical evaluation of the safety and performance of Terumo Corporation's membrane type plasma separator Donor Set GDS-1.<br>As a result, it was demonstrated that 174ml of plasma could be separated from approximately 408ml of blood in a little more than 10min, and that the N-N time from needle insertion to withdrawal was approximately 21min. The laboratory data of the donors were not remarkable after plasma separation, and no adverse effects plasma separation were observed. Accordingly, plasmapheresis by this system may be considered to be for practical purpose adequately safe. The activation of the coagulation, fibrinolysis and complement systems was so slight that biocompatibility was considered satisfactory.<br>This system which separates plasma from the blood by gravity is high of clinical use for its safety and procedural simplicity.

Journal

Details 詳細情報について

  • CRID
    1390001204909502080
  • NII Article ID
    130003706737
  • DOI
    10.3925/jjtc1958.36.20
  • ISSN
    18838383
    05461448
  • Text Lang
    ja
  • Data Source
    • JaLC
    • Crossref
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top